Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 415Cytarabine 337fludarabine phosphate 231Rituximab 206Methotrexate 199fludarabine 196venetoclax 174Azacitidine 174Busulfan 169Filgrastim 145Whole-Body Irradiation 143Mycophenolic Acid 143Peripheral Blood Stem Cell Transplantation 141Tacrolimus 138Etoposide 130Vincristine 113Melphalan 110Dexamethasone 110Cyclosporine 102Granulocyte Colony-Stimulating Factor 100Imatinib Mesylate 94Daunorubicin 91Antilymphocyte Serum 91Radiotherapy 84Decitabine 83Dasatinib 76Lenalidomide 75Doxorubicin 71Prednisone 69Idarubicin 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Polyethylene Glycols × Other hematologic neoplasm × Clear all
NCT01910012 2020-10-01

PH 2 ADI-PEG 20 Acute Myeloid Leukemia

Polaris Group

Phase 2 Completed
43 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡